CFTR and cystic fibrosis: LOF of CFTR or its reduced levels led to decrease in β-catenin protein in BECs both in vitro (SMCC) and in vivo (CF patient liver lysate), leading to nuclear translocation of p65, NF-κB activation, and increased expression of its pro-inflammatory chemokine targets.